Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
4,800 total articles
Vaxcyte's 31-valent conjugate vaccine (VAX-31) just cleared significant scientific and funding milestones. With positive Phase 1/2 data published in The Lancet and a $632.5M offering closed to fund late-stage programs and a planned $1B manufacturing buildout, the stock presents a tradeable long with asymmetric upside into late-2026/2027 regulatory …
Mitsui & Co. (MITSY) looks actionable after management laid out a new three-year plan and heavy interest from Berkshire Hathaway's team put trading houses back on investors' radars. At roughly $105.8B market cap, a 10% annual growth pathway and modest valuation (P/E ~18.8, P/B ~2.0) justify upgrading to a buy for a long-term (180 trading days) trad…
OpenText (OTEX) trades like a mature enterprise-software value play at roughly $5.8B market cap. With P/E ~13.3, EV/EBITDA ~6.9 and free cash flow near $878M, the stock looks priced for sideways growth. Recent operational signs, a public-sector distribution win and a planned divestiture of Vertica give catalysts for upside and a plausible path to a…
Prediction markets have received a lot of attention lately, but DraftKings' core licensed sportsbook and casino business remains the dominant, higher-margin route to monetizing sports fandom. With a market cap near $10.7B, positive free cash flow, and regulatory developments that favor licensed operators, DraftKings looks like a reasonable mid-term…
Gentex (GNTX) is a market leader in automotive vision and dimmable-glass technologies trading at roughly $4.9B market cap, with P/E ~13, EV/EBITDA ~8.4, and free cash flow north of $450M. The balance sheet is clean (debt-to-equity 0) and the company pays a steady $0.12 quarterly dividend. We like a tactically sized long position into $29 while prot…
Stoke Therapeutics is trading like a late-stage biotech with a blockbuster opportunity priced in. Zorevunersen's (reported in company materials as STK-001) potential to be disease-modifying in Dravet syndrome is the core bullish driver. The trade is long with an entry at $33.08, a $45.00 target and a $26.40 stop — horizon: long term (180 trading da…
Northeast Bank (NBN) is trading at a reasonable valuation against improving profitability and conservative leverage. With ROA/ROE above peers, solid free cash flow, and an upcoming dividend ex-date, the risk/reward favors a mid-term long. Enter at $125.00, stop at $118.00, target $140.00 over a 45 trading day horizon.
Tenet reported a mixed Q1 but raised full-year adjusted EPS guidance; fundamentals and cash flow support a constructive long trade from current levels. Entry at $183.29, target $235.00, stop $165.00 - long term (180 trading days).
Alnylam (ALNY) is digesting a strong multi-year story into a quieter calendar year. Valuation is rich, but revenue guidance and cash generation combined with a large TTR franchise and ongoing collaborations create a favorable risk-reward for a disciplined pullback buy. We lay out a mid-term trade plan with clear entry, stop, and target levels and a…
Ciena is converting a multi-billion-dollar backlog into revenue and free cash flow as hyperscalers build AI-optimized data centers. The stock is extended, but the fundamentals - fiscal Q1 revenue growth, a raised guide and a large orderbook - justify a long with a disciplined stop. Entry $537.34, target $700, stop $480; horizon: long term (180 trad…
SoFi has built scale in lending, deposits and investing that the market is under-pricing. With revenue growth running high, a healthy balance sheet and membership momentum, the Q1 selloff is an entry — not a verdict. This trade plan targets a recovery toward the mid-$20s over the next 180 trading days, with a protective stop below the recent low.
SoFi (SOFI) has retraced heavily since its November peak, but beneath the headline weakness is durable revenue growth, accelerating customer additions and a valuation that still looks reasonable given the growth profile. This trade idea targets a disciplined mid-term long: buy the dip near $16.00, cap risk with a $14.50 stop and aim for $20.00 as s…
Western Digital reported a Q3 beat on 04/30/2026, yet shares fell. The move looks driven by concerns around an NBM-related issue tied to SanDisk dynamics and NAND supply mix, combined with an already rich valuation and parabolic price action. We lay out a mid-term (45 trading days) short: entry $425.34, target $340.00, stop $460.00. This is a high-…
POET Technologies plunged after Marvell canceled orders and law firms opened class actions. The selloff looks overdone relative to the company’s addressable market in AI optics and the company’s IP platform. I outline a mid-term (45 trading days) trade: enter $6.90, stop $5.50, target $12.00, with clear catalysts and a strict risk framework.
Microsoft’s dip after an earnings-driven rotation into AI capex concerns created a tactical buying opportunity. With a $3.06T market cap, P/E ~24, $77.4B in free cash flow and Azure growth still in the high double-digits, the balance of data suggests upside. This trade idea lays out a mid-term (45 trading days) plan with entry, stop and target, plu…
Eli Lilly's Q1 2026 beat and guidance raise, driven by demand for Mounjaro and Zepbound plus a new oral GLP-1 approval, create a clear short-to-mid-term trading opportunity. Technicals confirm a fresh bullish leg and heavy volume today supports an immediate entry. Valuation is premium, but fundamentals and catalysts justify a measured buy with a de…
Plug Power has the headline ingredients for a turnaround: strong year-to-date performance, visible cost-cutting efforts, and market tailwinds in green hydrogen and AI data center demand. The stock trades at roughly $4.4B market cap with negative free cash flow but improving technical momentum. This trade idea is a disciplined long that banks on con…
Gentex (GNTX) is trading at an attractive entry point relative to cash flow, earnings and enterprise multiples while showing signs of margin recovery and product-led revenue diversification. We like a long bias with a defined entry at $23.00, stop at $20.50 and a $30.00 target over a long-term (180 trading days) horizon — a trade that balances soli…
Apple just delivered a clean beat and raised guidance while keeping capital intensity low. With $123.3B in free cash flow, a $100B buyback, and a services/AI monetization path that leverages installed devices rather than massive data-center spending, Apple offers a lower-capex route to participate in the AI upside. We upgrade the stock and lay out …
BWX Technologies (BWXT) combines a quasi-monopoly on U.S. naval reactors with an accelerating commercial footprint. The stock trades at a premium - reflecting stable government backlog and higher margins - but recent capacity buys and rising sector interest create a plausible path to meaningful revenue expansion. This trade idea favors a long posit…
Intel is trading near its 52-week high after a blistering April rally. Fundamentals show improving data-center revenue and government/AI tailwinds, while valuation and technical indicators look stretched. This trade idea outlines a disciplined long with an entry at $95.00, a stop at $87.00, and a $120.00 target over a 180-trading-day window — a cal…
Nvidia is trading ~7% off its 52-week high after a sharp two-day pullback. The business fundamentals remain intact - enormous free cash flow, industry-leading returns on equity, and near-zero net leverage - while technicals show the stock finding support near its 20/50-day moving averages. This trade targets a measured rebound to $230 with a tight …
Franklin Resources (BEN) looks like a classic value + momentum trade. The stock is trading near $29.98, yields roughly 4.4% and shows bullish technical momentum (RSI ~76, MACD bullish). Fundamentals support the case: $873.5M of free cash flow, a market cap near $15.6B and inexpensive price-to-book around 1.28. I’m advocating a long trade with an en…
Amazon remains one of the clearest long-term winners in cloud and retail, but the stock is materially overbought after a month-long rally. This trade idea lays out a disciplined plan: wait for a controlled pullback to enter, a tight stop to manage a momentum reversal, and a realistic mid-term target while keeping the long-term thesis intact.
Rubrik (RBRK) is trading near $54 after a painful derating from last year’s highs. The company is growing revenue north of $1.4B annualized, generating positive free cash flow, and has concrete product wins with Microsoft and sovereign cloud offerings. For investors willing to tolerate execution risk and near-term margin pressure, this is a long-te…
